FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Protein Expr Purif / Factors affecting recombinant Western equine encephalitis vi...
Protein expression and purification2011; 80(2); 274-282; doi: 10.1016/j.pep.2011.08.002

Factors affecting recombinant Western equine encephalitis virus glycoprotein production in the baculovirus system.

Abstract: In an effort to produce processed, soluble Western equine encephalitis virus (WEEV) glycoproteins for subunit therapeutic vaccine studies, we isolated twelve recombinant baculoviruses designed to express four different WEEV glycoprotein constructs under the transcriptional control of three temporally distinct baculovirus promoters. The WEEV glycoprotein constructs encoded full-length E1, the E1 ectodomain, an E26KE1 polyprotein precursor, and an artificial, secretable E2E1 chimera. The three different promoters induced gene expression during the immediate early (ie1), late (p6.9), and very late (polh) phases of baculovirus infection. Protein expression studies showed that the nature of the WEEV construct and the timing of expression both influenced the quantity and quality of recombinant glycoprotein produced. The full-length E1 product was insoluble, irrespective of the timing of expression. Each of the other three constructs yielded soluble products and, in these cases, the timing of expression was important, as higher protein processing efficiencies were generally obtained at earlier times of infection. However, immediate early expression did not yield detectable levels of every WEEV product, and expression during the late (p6.9) or very late (polh) phases of infection provided equal or higher amounts of processed, soluble product. Thus, while earlier foreign gene expression can provide higher recombinant glycoprotein processing efficiencies in the baculovirus system, in the case of the WEEV glycoproteins, earlier expression did not provide larger amounts of high quality, soluble recombinant glycoprotein product.
Copyright © 2011 Elsevier Inc. All rights reserved.
Get Full Text
Publication Date: 2011-08-16 PubMed ID: 21864686PubMed Central: PMC3196263DOI: 10.1016/j.pep.2011.08.002Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • N.I.H.
  • Extramural

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article focuses on the production of soluble Western equine encephalitis virus (WEEV) glycoproteins using the baculovirus system and the factors that affect the quantity and the quality of this production. It presents the outcomes of various constructs and promoters and how they influence the process.

Experiment Design:

  • The researchers created twelve recombinant baculoviruses. These are made to express four different WEEV glycoprotein constructs.
  • The purpose of these constructs is to express the full-length E1, the E1 ectodomain, an E26KE1 polyprotein precursor, and an artificial, secretable E2E1 chimera.
  • The constructs come under the transcriptional control of three different baculovirus promoters, which induce gene expression during the immediate early (ie1), late (p6.9), and very late (polh) phases of baculovirus infection.

Results:

  • The observed results showed that the type of WEEV construct and the timing of expression significantly influenced the amount and quality of the recombinant glycoprotein produced.
  • The full-length E1 product resulted in an insoluble state, regardless of when it was expressed.
  • Each of the other three constructs produced soluble products at different times of expression with higher protein processing efficiencies usually achieved at earlier times of infection.
  • The immediate early expression did not yield detectable levels for all WEEV products.
  • Expression during the late (p6.9) or very late (polh) phases of infection provided equal or larger amounts of processed, soluble product.

Conclusion:

  • Thus, the study concludes that while early foreign gene expression can result in higher recombinant glycoprotein processing efficiencies in the baculovirus system, in the case of the WEEV glycoproteins, earlier expression did not provide larger amounts of high-quality, soluble recombinant glycoprotein product.
  • This shows the complex relationship between the timing of gene expression and the type of construct used in the production of recombinant glycoproteins for therapeutic vaccine studies.

Cite This Article

APA
Toth AM, Geisler C, Aumiller JJ, Jarvis DL. (2011). Factors affecting recombinant Western equine encephalitis virus glycoprotein production in the baculovirus system. Protein Expr Purif, 80(2), 274-282. https://doi.org/10.1016/j.pep.2011.08.002

Publication

Protein expression and purification
ISSN: 1096-0279
NlmUniqueID: 9101496
Country: United States
Language: English
Volume: 80
Issue: 2
Pages: 274-282

Researcher Affiliations

Toth, Ann M
  • Department of Molecular Biology, University of Wyoming, Laramie, WY 82071, USA.
Geisler, Christoph
    Aumiller, Jared J
      Jarvis, Donald L

        MeSH Terms

        • Animals
        • Baculoviridae / genetics
        • Baculoviridae / isolation & purification
        • Baculoviridae / metabolism
        • Baculoviridae / pathogenicity
        • Blotting, Western
        • Cell Line
        • Cloning, Molecular
        • Encephalitis Virus, Western Equine / chemistry
        • Encephalitis Virus, Western Equine / genetics
        • Gene Expression Regulation, Viral
        • Genes, Viral
        • Genetic Vectors / genetics
        • Genetic Vectors / metabolism
        • Glycoproteins / genetics
        • Glycoproteins / isolation & purification
        • Glycoproteins / metabolism
        • Glycosylation
        • Promoter Regions, Genetic
        • Recombinant Proteins / genetics
        • Recombinant Proteins / isolation & purification
        • Recombinant Proteins / metabolism
        • Solubility
        • Spodoptera
        • Time Factors
        • Transcription, Genetic
        • Viral Envelope Proteins / genetics
        • Viral Envelope Proteins / isolation & purification
        • Viral Envelope Proteins / metabolism

        Grant Funding

        • U54 AI065357-06 / NIAID NIH HHS
        • U54 AI-065357 / NIAID NIH HHS
        • P41 RR005351 / NCRR NIH HHS
        • P41 RR005351-19 / NCRR NIH HHS
        • U54 AI065357 / NIAID NIH HHS

        References

        This article includes 37 references
        1. Jarvis DL. Baculovirus-insect cell expression systems.. Methods Enzymol 2009;463:191-222.
          pubmed: 19892174doi: 10.1016/s0076-6879(09)63014-7google scholar: lookup
        2. Summers MD, Smith GE. Texas Agricultural Experimental Station Bulletin 1555. Texas Agricultural Experimental Station; College Station, TX: 1987.
        3. O’Reilly DR, Miller LK, Luckow VA. Baculovirus Expression Vectors. W. H. Freeman and Co.; New York: 1992.
        4. . FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).. MMWR Morb Mortal Wkly Rep 2010 May 28;59(20):626-9.
          pubmed: 20508593
        5. DeFrancesco L. Landmark approval for Dendreon's cancer vaccine.. Nat Biotechnol 2010 Jun;28(6):531-2.
          pubmed: 20531312doi: 10.1038/nbt0610-531google scholar: lookup
        6. Sridhar P, Panda AK, Pal R, Talwar GP, Hasnain SE. Temporal nature of the promoter and not relative strength determines the expression of an extensively processed protein in a baculovirus system.. FEBS Lett 1993 Jan 11;315(3):282-6.
          pubmed: 8422919doi: 10.1016/0014-5793(93)81179-4google scholar: lookup
        7. Rankl NB, Rice JW, Gurganus TM, Barbee JL, Burns DJ. The production of an active protein kinase C-delta in insect cells is greatly enhanced by the use of the basic protein promoter.. Protein Expr Purif 1994 Aug;5(4):346-56.
          pubmed: 7950381doi: 10.1006/prep.1994.1051google scholar: lookup
        8. Chazenbalk GD, Rapoport B. Expression of the extracellular domain of the thyrotropin receptor in the baculovirus system using a promoter active earlier than the polyhedrin promoter. Implications for the expression of functional highly glycosylated proteins.. J Biol Chem 1995 Jan 27;270(4):1543-9.
          pubmed: 7829482doi: 10.1074/jbc.270.4.1543google scholar: lookup
        9. Bozon V, Remy JJ, Pajot-Augy E, Couture L, Biache G, Severini M, Salesse R. Influence of promoter and signal peptide on the expression and secretion of recombinant porcine LH extracellular domain in baculovirus/lepidopteran cells or the caterpillar system.. J Mol Endocrinol 1995 Jun;14(3):277-84.
          pubmed: 7669219doi: 10.1677/jme.0.0140277google scholar: lookup
        10. Jarvis DL, Weinkauf C, Guarino LA. Immediate-early baculovirus vectors for foreign gene expression in transformed or infected insect cells.. Protein Expr Purif 1996 Sep;8(2):191-203.
          pubmed: 8812860doi: 10.1006/prep.1996.0092google scholar: lookup
        11. Jarvis DL, Summers MD. Glycosylation and secretion of human tissue plasminogen activator in recombinant baculovirus-infected insect cells.. Mol Cell Biol 1989 Jan;9(1):214-23.
          pmc: PMC362163pubmed: 2494430doi: 10.1128/mcb.9.1.214-223.1989google scholar: lookup
        12. Strauss JH, Strauss EG. The alphaviruses: gene expression, replication, and evolution.. Microbiol Rev 1994 Sep;58(3):491-562.
          pmc: PMC372977pubmed: 7968923doi: 10.1128/mr.58.3.491-562.1994google scholar: lookup
        13. Weaver SC, Reisen WK. Present and future arboviral threats.. Antiviral Res 2010 Feb;85(2):328-45.
          pmc: PMC2815176pubmed: 19857523doi: 10.1016/j.antiviral.2009.10.008google scholar: lookup
        14. Sidwell RW, Smee DF. Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control.. Antiviral Res 2003 Jan;57(1-2):101-11.
          pubmed: 12615306doi: 10.1016/s0166-3542(02)00203-6google scholar: lookup
        15. Aumiller JJ, Hollister JR, Jarvis DL. Molecular cloning and functional characterization of beta-N-acetylglucosaminidase genes from Sf9 cells.. Protein Expr Purif 2006 Jun;47(2):571-90.
          pmc: PMC1592231pubmed: 16427309doi: 10.1016/j.pep.2005.11.026google scholar: lookup
        16. Aumiller JJ, Hollister JR, Jarvis DL. A transgenic insect cell line engineered to produce CMP-sialic acid and sialylated glycoproteins.. Glycobiology 2003 Jun;13(6):497-507.
          pmc: PMC3612900pubmed: 12626399doi: 10.1093/glycob/cwg051google scholar: lookup
        17. Kitts PA, Possee RD. A method for producing recombinant baculovirus expression vectors at high frequency.. Biotechniques 1993 May;14(5):810-7.
          pubmed: 8512707
        18. Logue CH, Bosio CF, Welte T, Keene KM, Ledermann JP, Phillips A, Sheahan BJ, Pierro DJ, Marlenee N, Brault AC, Bosio CM, Singh AJ, Powers AM, Olson KE. Virulence variation among isolates of western equine encephalitis virus in an outbred mouse model.. J Gen Virol 2009 Aug;90(Pt 8):1848-1858.
          pmc: PMC2887574pubmed: 19403754doi: 10.1099/vir.0.008656-0google scholar: lookup
        19. Zhang W, Mukhopadhyay S, Pletnev SV, Baker TS, Kuhn RJ, Rossmann MG. Placement of the structural proteins in Sindbis virus.. J Virol 2002 Nov;76(22):11645-58.
          pmc: PMC136788pubmed: 12388725doi: 10.1128/jvi.76.22.11645-11658.2002google scholar: lookup
        20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.. Nature 1970 Aug 15;227(5259):680-5.
          pubmed: 5432063doi: 10.1038/227680a0google scholar: lookup
        21. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979.. Biotechnology 1992;24:145-9.
          pubmed: 1422008
        22. Blake MS, Johnston KH, Russell-Jones GJ, Gotschlich EC. A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.. Anal Biochem 1984 Jan;136(1):175-9.
          pubmed: 6424501doi: 10.1016/0003-2697(84)90320-8google scholar: lookup
        23. Hodgson LA, Ludwig GV, Smith JF. Expression, processing, and immunogenicity of the structural proteins of Venezuelan equine encephalitis virus from recombinant baculovirus vectors.. Vaccine 1999 Mar 5;17(9-10):1151-60.
          pubmed: 10195627doi: 10.1016/s0264-410x(98)00335-1google scholar: lookup
        24. Gauci PJ, Wu JQ, Rayner GA, Barabé ND, Nagata LP, Proll DF. Identification of Western equine encephalitis virus structural proteins that confer protection after DNA vaccination.. Clin Vaccine Immunol 2010 Jan;17(1):176-9.
          pmc: PMC2812089pubmed: 19923571doi: 10.1128/cvi.00377-09google scholar: lookup
        25. Hunt AR, Roehrig JT. Biochemical and biological characteristics of epitopes on the E1 glycoprotein of western equine encephalitis virus.. Virology 1985 Apr 30;142(2):334-46.
          pubmed: 2414904doi: 10.1016/0042-6822(85)90342-3google scholar: lookup
        26. Swayze RD, Bhogal HS, Barabé ND, McLaws LJ, Wu JQ. Envelope protein E1 as vaccine target for western equine encephalitis virus.. Vaccine 2011 Jan 17;29(4):813-20.
          pubmed: 21084062doi: 10.1016/j.vaccine.2010.11.009google scholar: lookup
        27. Shabman RS, Rogers KM, Heise MT. Ross River virus envelope glycans contribute to type I interferon production in myeloid dendritic cells.. J Virol 2008 Dec;82(24):12374-83.
          pmc: PMC2593332pubmed: 18922878doi: 10.1128/jvi.00985-08google scholar: lookup
        28. Oker-Blom C, Summers MD. Expression of Sindbis virus 26S cDNA in Spodoptera frugiperda (Sf9) cells, using a baculovirus expression vector.. J Virol 1989 Mar;63(3):1256-64.
          pmc: PMC247822pubmed: 2644447doi: 10.1128/jvi.63.3.1256-1264.1989google scholar: lookup
        29. Tello D, Rodríguez-Rodríguez M, Yélamos B, Gómez-Gutiérrez J, Ortega S, Pacheco B, Peterson DL, Gavilanes F. Expression and structural properties of a chimeric protein based on the ectodomains of E1 and E2 hepatitis C virus envelope glycoproteins.. Protein Expr Purif 2010 Jun;71(2):123-31.
          pubmed: 20176110doi: 10.1016/j.pep.2010.02.012google scholar: lookup
        30. Xiang ZH, Cai WJ, Zhao P, Kong LB, Ye LB, Wu ZH. Purification and application of bacterially expressed chimeric protein E1E2 of hepatitis C virus.. Protein Expr Purif 2006 Sep;49(1):95-101.
          pubmed: 16600629doi: 10.1016/j.pep.2006.02.013google scholar: lookup
        31. Maynard J, Georgiou G. Antibody engineering.. Annu Rev Biomed Eng 2000;2:339-76.
          pubmed: 11701516doi: 10.1146/annurev.bioeng.2.1.339google scholar: lookup
        32. Tarentino AL, Maley F. Purification and properties of an endo-beta-N-acetylglucosaminidase from Streptomyces griseus.. J Biol Chem 1974 Feb 10;249(3):811-7.
          pubmed: 4204552
        33. Tarentino AL, Gómez CM, Plummer TH Jr. Deglycosylation of asparagine-linked glycans by peptide:N-glycosidase F.. Biochemistry 1985 Aug 13;24(17):4665-71.
          pubmed: 4063349doi: 10.1021/bi00338a028google scholar: lookup
        34. Oker-Blom C, Pettersson RF, Summers MD. Baculovirus polyhedrin promoter-directed expression of rubella virus envelope glycoproteins, E1 and E2, in Spodoptera frugiperda cells.. Virology 1989 Sep;172(1):82-91.
          pubmed: 2672567doi: 10.1016/0042-6822(89)90109-8google scholar: lookup
        35. Neufeld KL, Richards OC, Ehrenfeld E. Expression and characterization of poliovirus proteins 3BVPg, 3Cpro, and 3Dpol in recombinant baculovirus-infected Spodoptera frugiperda cells.. Virus Res 1991 May;19(2-3):173-88.
          pubmed: 1654015doi: 10.1016/0168-1702(91)90044-vgoogle scholar: lookup
        36. Matsuura Y, Harada S, Suzuki R, Watanabe Y, Inoue Y, Saito I, Miyamura T. Expression of processed envelope protein of hepatitis C virus in mammalian and insect cells.. J Virol 1992 Mar;66(3):1425-31.
          pmc: PMC240866pubmed: 1310756doi: 10.1128/jvi.66.3.1425-1431.1992google scholar: lookup
        37. Baumert TF, Ito S, Wong DT, Liang TJ. Hepatitis C virus structural proteins assemble into viruslike particles in insect cells.. J Virol 1998 May;72(5):3827-36.
          pmc: PMC109606pubmed: 9557666doi: 10.1128/jvi.72.5.3827-3836.1998google scholar: lookup

        Citations

        This article has been cited 15 times.
        1. Xing Y, Li X, Gao X, Dong Q. Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein.. Front Genet 2020;11:783.
          doi: 10.3389/fgene.2020.00783pubmed: 32765596google scholar: lookup
        2. Targovnik AM, Ferrari A, Mc Callum GJ, Arregui MB, Smith I, Bracco LF, Alfonso V, López MG, Martínez-Solís M, Herrero S, Miranda MV. Highly efficient production of rabies virus glycoprotein G ectodomain in Sf9 insect cells.. 3 Biotech 2019 Nov;9(11):385.
          doi: 10.1007/s13205-019-1920-4pubmed: 31656723google scholar: lookup
        3. Lyu SJ, Yuan XM, Zhang HQ, Shi WD, Hang XY, Liu L, Wu YL. Isolation and characterization of a novel strain (YH01) of Micropterus salmoides rhabdovirus and expression of its glycoprotein by the baculovirus expression system.. J Zhejiang Univ Sci B 2019 Sept.;20(9):728-739.
          doi: 10.1631/jzus.B1900027pubmed: 31379143google scholar: lookup
        4. Palomares LA, Srivastava IK, Ramírez OT, Cox MMJ. Glycobiotechnology of the Insect Cell-Baculovirus Expression System Technology.. Adv Biochem Eng Biotechnol 2021;175:71-92.
          doi: 10.1007/10_2018_61pubmed: 29886511google scholar: lookup
        5. Rico AB, Phillips AT, Schountz T, Jarvis DL, Tjalkens RB, Powers AM, Olson KE. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.. Virology 2016 Dec;499:30-39.
          doi: 10.1016/j.virol.2016.08.023pubmed: 27632563google scholar: lookup
        6. Maghodia AB, Geisler C, Jarvis DL. Characterization of an Sf-rhabdovirus-negative Spodoptera frugiperda cell line as an alternative host for recombinant protein production in the baculovirus-insect cell system.. Protein Expr Purif 2016 Jun;122:45-55.
          doi: 10.1016/j.pep.2016.02.014pubmed: 26923062google scholar: lookup
        7. Geisler C, Mabashi-Asazuma H, Kuo CW, Khoo KH, Jarvis DL. Engineering β1,4-galactosyltransferase I to reduce secretion and enhance N-glycan elongation in insect cells.. J Biotechnol 2015 Jan 10;193:52-65.
          doi: 10.1016/j.jbiotec.2014.11.013pubmed: 25462875google scholar: lookup
        8. Reed DS, Glass PJ, Bakken RR, Barth JF, Lind CM, da Silva L, Hart MK, Rayner J, Alterson K, Custer M, Dudek J, Owens G, Kamrud KI, Parker MD, Smith J. Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.. J Virol 2014 Oct;88(20):12077-86.
          doi: 10.1128/JVI.01406-14pubmed: 25122801google scholar: lookup
        9. Toth AM, Kuo CW, Khoo KH, Jarvis DL. A new insect cell glycoengineering approach provides baculovirus-inducible glycogene expression and increases human-type glycosylation efficiency.. J Biotechnol 2014 Jul 20;182-183:19-29.
          doi: 10.1016/j.jbiotec.2014.04.011pubmed: 24768688google scholar: lookup
        10. Mabashi-Asazuma H, Kuo CW, Khoo KH, Jarvis DL. A novel baculovirus vector for the production of nonfucosylated recombinant glycoproteins in insect cells.. Glycobiology 2014 Mar;24(3):325-40.
          doi: 10.1093/glycob/cwt161pubmed: 24362443google scholar: lookup
        11. Phillips AT, Schountz T, Toth AM, Rico AB, Jarvis DL, Powers AM, Olson KE. Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses.. J Virol 2014 Feb;88(3):1771-80.
          doi: 10.1128/JVI.02297-13pubmed: 24257615google scholar: lookup
        12. Liu F, Wu X, Li L, Liu Z, Wang Z. Use of baculovirus expression system for generation of virus-like particles: successes and challenges.. Protein Expr Purif 2013 Aug;90(2):104-16.
          doi: 10.1016/j.pep.2013.05.009pubmed: 23742819google scholar: lookup
        13. Lin CH, Jarvis DL. Utility of temporally distinct baculovirus promoters for constitutive and baculovirus-inducible transgene expression in transformed insect cells.. J Biotechnol 2013 May 10;165(1):11-7.
          doi: 10.1016/j.jbiotec.2013.02.007pubmed: 23458965google scholar: lookup
        14. Phillips AT, Stauft CB, Aboellail TA, Toth AM, Jarvis DL, Powers AM, Olson KE. Bioluminescent imaging and histopathologic characterization of WEEV neuroinvasion in outbred CD-1 mice.. PLoS One 2013;8(1):e53462.
          doi: 10.1371/journal.pone.0053462pubmed: 23301074google scholar: lookup
        15. Geisler C, Jarvis DL. Innovative use of a bacterial enzyme involved in sialic acid degradation to initiate sialic acid biosynthesis in glycoengineered insect cells.. Metab Eng 2012 Nov;14(6):642-52.
          doi: 10.1016/j.ymben.2012.08.005pubmed: 23022569google scholar: lookup
        Subscribe to our newsletter
        Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.